Method of inducing cell proliferation using fibroin

Details Method of inducing cell proliferation using fibroin Method of inducing cell proliferation using fibroin

2007-04-05

2011-12-06

Azpuru, Carlos (Department: 1617)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Implant or insert

Reexamination Certificate

active

08071118

ABSTRACT:
A bioactive material is made using fibroin solutions and suspensions designed to support the constructions, repair, regeneration or augmentation of bone and other tissues of the body. The fibroin solutions, suspensions, and composites can be injected to fill cavities or to replace missing tissue. After injection, the materials can produce a scaffold capable of promoting tissue regeneration while degrading. The ability to inject the fibroin solutions, suspensions and composites can reduce the need for many types of surgical procedures that are used to replace or repair bone and other tissues. The fibroin solutions and suspensions are particularly useful for methods of tissue construction and/or repair.

REFERENCES:
patent: 4233211 (1980-11-01), Ohtomo et al.
patent: 4490984 (1985-01-01), Hongo et al.
patent: 4675189 (1987-06-01), Kent et al.
patent: 4818291 (1989-04-01), Iwatsuki et al.
patent: 5480644 (1996-01-01), Freed
patent: 5490984 (1996-02-01), Freed
patent: 5599852 (1997-02-01), Scopelianos et al.
patent: 5728752 (1998-03-01), Scopelianos et al.
patent: 5824333 (1998-10-01), Scopelianos et al.
patent: 5863984 (1999-01-01), Doillon et al.
patent: 5939323 (1999-08-01), Valentini et al.
patent: 6140452 (2000-10-01), Felt et al.
patent: 6218357 (2001-04-01), Terauchi
patent: 0 513 803 (1992-11-01), None
patent: WO 01/25403 (2001-04-01), None
patent: WO 02/29141 (2002-04-01), None
Chen, et al.; “Scaffold Design for Tissue Engineering”; Macromol. Biosci.; 2; pp. 67-77; (2002).
Shin, et al.; “Biomimetic Materials for Tissue Engineering”; Biomaterials; 24; pp. 4353-4364; (2003).
Spector, Myron; “Biomaterials-based Tissue Engineering and Regenerative Medicine Solutions to Musculoskeletal Problems”; Swiss Med Wkly; 136; pp. 293-301; (2006).
Kesenci, K., et al; “Poly(e-casprolactone-co-D, L-lactide) / silk fibroin composite materials: preparation and characterization”J. Biomater Sci. Polym. Ed 2001; 12 (3): pp. 337-351.
Kurosaki, S., et al.; “Fibroin allergy”;J. Nippon Med Sch 1999: 66(1); pp. 41-44.
Motta, A., et al.; “Regenerated Silk Fibroin Films: Thermal and Cynamic Mechanical Analysis”;Macromol. Chem. Phys. 2002, 203, pp. 1658-1665.
Motta, A. et al.; “Silk Derived Fibroin Membranes for Biomedical Use;Third International Symposium on Frontiers in Biomedical Plymers Including Polymer Therapeutics—From Labroatory to Clinical Pracitce” Abstract, Sbigha Japan, May 1999.
Santin, M., et al.; “In vitro evaluationof the inflammatory potential of the silk fibroin”;J. Biomed. Maker. Res 1999, 46(43): pp. 382-389.
Tsukada, M., et al.; “Structural Changes of Silk Fibroin Membranes Induced by Immersion in Methanol Aqueous Solutions”;Journal of Polymer Science: Part B: Polymer Physics, vol. 32, (1994); pp. 961-968.
Database WPI, Section Ch, Week 198123, Derwent Publications Ltd., London, GB; AN 1981-40786D XP002235614 & JP 56 040156 A (Kanebo Ltd), Apr. 16, 1981, Abstract.
Database WPI Section Ch, Week 200147, Derwent Publications Ltd., London,G B; AN 2001-433340 XP002235615 & CN 1 293 952 A (Univ Wuhan) May 9, 2001, Abstract.
Database WPI Section Ch, Week 199001 Derwent Publications Ltd., London, GB; AN 1990-004589 XP002235616 & JP 01 288269 A (Toa Nenryo Kogyo KK), Nov. 20, 1989, Abstract.
Yang G et al.: “Structure and microporous formation of cellulose/silk fibroin blend membranes—I Effect of coagulants” Journal of Membrane Science, Elsevier Science, Amsterdam, NL, vol. 177, No. 1-2, Aug. 30, 2000, pp. 153-161 XP004215319 ISSN: 0376-7388 ,Abstract.
Kweon H et al.: “Structural and thermal characteristics of Antheraea pernyi silk fibroin/chitosan blend film” Polymer, Elsevier Science Publishers B.V., GB, vol. 42, No. 15, Jul. 2001, pp. 6651-6656, XP004235369 ISSN: 0032-3861, Abstract.
Database WPI Section Ch, Week 198947, Derwent Publications Ltd., London, GB; AN 1989-343221, XP002235613 & JP 01 254621 A (Terumo Corp), Oct. 11, 1989, Abstract.
International Search Report, mailed Apr. 8, 2003.
Havawa, et al.; “New Oral Dosage form for Elderly Patients: Preparation and Characterization of Silk Fibroin Gel”; Chem. Pharm. Bull, vol. 43, No. 2, 1995; pp. 284-288.
Database PAJ; JP 11 18544 A (Minoura Norihiko); May 11, 1989.
International Search Report; International Application No. UCT-0027-PCT; International Filing Date Oct. 25, 2002 (9 pgs).
International Search Report; International Application No. UCT PCT/US 02/34252; International Filing Date Oct. 25, 2002; Date of Mailing Apr. 8, 2003.
CA 2,466,001, filed Oct. 24, 2002; First Office Action dated Feb. 5, 2010; 3 pages.

Affiliated with

Also associated with

Rating

Method of inducing cell proliferation using fibroin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of inducing cell proliferation using fibroin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inducing cell proliferation using fibroin will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4301818